Founder and Managing Director of Sun Pharmaceutical Industries, a pharmaceuticals company based in Mumbai.
Dilip Shanghvi is Founder and Managing Director of Sun Pharmaceutical Industries, a pharmaceuticals company based in Mumbai, founded in 1983.
Mumbai-headquartered pharmaceutical company, India's largest by revenue and among the world's biggest generic drugmakers. It has been shifting its earnings mix towards specialty products in dermatology, ophthalmology and oncology, with ILUMYA among its lead specialty assets. Listed on the NSE and BSE.
Company profile →ProfileILUMYA (tildrakizumab-asmn) receives first US FDA approval, for adults with moderate-to-severe plaque psoriasis.
US FDA approves its supplemental Biologics License Application for ILUMYA (tildrakizumab-asmn) in adults with active psoriatic arthritis, expanding the IL-23 inhibitor beyond its 2018 plaque psoriasis indication.
Dilip Shanghvi is the Founder and Managing Director of Sun Pharmaceutical Industries, a pharmaceuticals company based in Mumbai, founded in 1983.
StartupFox's company records list Dilip Shanghvi as Founder and Managing Director of Sun Pharmaceutical Industries.
Sun Pharmaceutical Industries is headquartered in Mumbai, India.
This profile is compiled by the StartupFox desk from company announcements, regulatory filings and our own reporting. If this is you, you can verify it with LinkedIn and edit it.
